Y. Doi

Molecular Medicine · 2016–2020

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Y. Doi trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. L. Poirel
  2. P. Nordmann

Papers from Y. Doi's perspective

Ordered by how strongly the researchers Y. Doi trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (Clinical Microbiology and Infection)
  2. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
  3. OXA-48-like carbapenemases: the phantom menace. (Journal of Antimicrobial Chemotherapy)
  4. Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy)
  5. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria (Frontiers in Microbiology)
  6. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes (Clinical Microbiology Reviews)
  7. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. (Clinical Infectious Diseases)
  8. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India (Antimicrobial Agents and Chemotherapy)
  9. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy)
  10. Emerging carbapenemases in Gram-negative aerobes. (Clinical Microbiology and Infection)

Their papers